Heart Disease News and Research

Latest Heart Disease News and Research

Platelets play important role in cerebral malaria: Research

Scientists are making strides against cerebral malaria, a fatal form of malaria in children that can ravage the brain and is extremely difficult to treat. New research points to platelets - known for their role in blood clotting - as playing an important role in the disease, stimulating the immune system and turning on molecules that increase inflammation. The inflammation leads to the obstruction of blood vessels in the brain, causing brain damage similar to that seen with a stroke.

2 Jun 2010

Survey: 58% of Australians worry about brain health, age-related degenerative brain disease

The majority of Australians (58%) are worried about their brain health and the threat of age-related degenerative brain disease, according to a new survey. The national survey was commissioned by leading medical research institute Neuroscience Research Australia and polled 1000 Australians aged 18 to over 75.

2 Jun 2010

McGill University granted 'Orphan Drug Designation' for pulmonary infection drug fenretinide

In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.

2 Jun 2010

Cancer patients should find ways to be physically active during and after treatment: New national guidelines

Cancer patients who've been told to rest and avoid exercise can - and should - find ways to be physically active both during and after treatment, according to new national guidelines. Kathryn Schmitz, PhD, MPH, an associate professor of Epidemiology and Biostatistics and a member of the Abramson Cancer Center at the University of Pennsylvania School of Medicine, will present these guidelines at an educational session at the 2010 meeting of the American Society of Clinical Oncology, aimed at making cancer exercise rehabilitation programs as common as those offered to people who have had heart attacks or undergone cardiac surgery.

2 Jun 2010

Postdoctoral scientists receive NYSCF-Druckenmiller Fellowship award

The New York Stem Cell Foundation (NYSCF) today announced the award of eight new NYSCF-Druckenmiller Fellows. These postdoctoral scientists join 15 accomplished stem cell researchers from leading institutions who have been supported by the program since 2006. NYSCF has awarded 23 fellowships to date.

2 Jun 2010

Men with ED are at increased risk of high CACS: Researchers

In the largest study to date evaluating erectile dysfunction and coronary artery calcification, researchers at Mount Sinai School of Medicine have determined that men with ED are at a significantly increased risk of high coronary artery calcification scores, a known predictor of future cardiovascular events.

2 Jun 2010

CoaguSense unveils first portable point-of-care PT/INR Monitoring System for patients on oral anticoagulants

CoaguSense™, Inc., a diagnostic device company that has been in stealth mode for the past two years, today unveiled the first portable point-of-care Prothrombin Time/International Normalized Ratio (PT/INR) analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications such as Coumadin® or warfarin.

2 Jun 2010

Targeted Genetics reports net income of $1.8M for fourth-quarter 2009 compared to net loss of $10.8M in 2008

Targeted Genetics Corporation today announced its financial results for the fourth quarter and full year ended December 31, 2009.

1 Jun 2010

Odds of surviving cardiac arrest may depend on neighborhood: Study

The odds of surviving cardiac arrest may depend on which part of town you call home and whether anyone in the neighborhood comes to your rescue by attempting to perform cardiopulmonary resuscitation, according to a first-of-its-kind study in the June issue of the Annals of Internal Medicine.

1 Jun 2010

Race matching among donors and recipients has no effect on survival rates: Study

Transplant surgeons at Johns Hopkins who have reviewed the medical records of more than 20,000 heart transplant patients say that it is not simply racial differences, but rather flaws in the health care system, along with type of insurance and education levels, in addition to biological factors, that are likely the causes of disproportionately worse outcomes after heart transplantation in African Americans.

1 Jun 2010

Canadian Diabetes Association supports TELUS Health Solutions' new online consumer ehealth service

Access to relevant health information is crucial when it comes to successful diabetes management. The Canadian Diabetes Association is pleased to support TELUS Health Solutions' launch of TELUS health space - an innovative new online consumer health service for Canadians and their healthcare providers

1 Jun 2010

Alcohol consumption in Portugal represents heavy economic burden for that country's health system

The World Health Organization has estimated that 3.2 percent of the "burden of disease" around the world is attributable to the consumption of alcohol. Portugal is currently ranked eighth in the world in alcohol consumption. A new study has found alcohol consumption in Portugal represents a heavy economic burden for that country's health system.

1 Jun 2010

Women unaware of their heart disease risk: Report

The Australian Institute of Health and Welfare has come up with results of their study funded by the National Heart Foundation that warns Australian women of their heart disease risk. It says that heart disease is the leading killer of Australian women and most women (eight out of ten) think that heart disease kills only “old men”.

31 May 2010

DNAzymes and substrates constitute a platform for logic operations essential to computational processes

New perspectives are opening up in bio-engineering thanks to research jointly carried out by teams of chemists at the University of Liège and the Hebrew University of Jerusalem within the framework of the European MOLOC project (Molecular Logic Circuits). This work has led to the publication of two important publications, one straight after the other, in the Nature Nanotechnology journal.

31 May 2010

Brain's cardiovascular, hormonal and asymmetric activation response when we get angry: UV scientists

When we get angry, the heart rate, arterial tension and testosterone production increases, cortisol (the stress hormone) decreases, and the left hemisphere of the brain becomes more stimulated. This is indicated by a new investigation lead by scientists from the University of Valencia that analyses the changes in the brain's cardiovascular, hormonal and asymmetric activation response when we get angry.

31 May 2010

FAIR-HF study: Ferinject improves renal function in patients with CHF and iron deficiency

Results of a subanalysis from the FAIR-HF study demonstrate that correcting iron deficiency with Ferinject (ferric carboxymaltose) can improve renal function in chronic heart failure patients. Ferinject is an intravenous iron product used to treat iron deficiency and iron deficiency anaemia.

From CSL Ltd 31 May 2010

Researchers identify pattern of gene expression in kidney transplant recipients who don't need anti-rejection drugs

Researchers have identified a distinct pattern of gene expression in the largest reported group of kidney transplant recipients who have not rejected the transplant kidneys even though they stopped taking anti-rejection drugs. This finding may help identify other transplant recipients who could safely reduce or end use of immunosuppressive therapy. In 2008, more than 80,000 people in the United States were living with a kidney transplant.

31 May 2010

Celladon announces 6-month data from Phase 2 clinical trial of MYDICAR in advanced heart failure patients

Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that six-month data from its Phase 2 clinical trial of MYDICAR® show improvements in clinical outcomes and disease markers in advanced heart failure patients treated with the genetically targeted enzyme replacement therapy.

31 May 2010

Adenosine plays major role in parlaying effects of acupuncture

Scientists have taken another important step toward understanding just how sticking needles into the body can ease pain.

31 May 2010

Overall increase of cesarean births not due to maternal request

Fewer than two per cent of cesarean births in British Columbia were a result of maternal request, but the number of cesarean and assisted vaginal deliveries varied widely across health regions in B.C., according to a new study by University of British Columbia researchers.

31 May 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Platelets play important role in cerebral malaria: Research

Survey: 58% of Australians worry about brain health, age-related degenerative brain disease

McGill University granted 'Orphan Drug Designation' for pulmonary infection drug fenretinide

Cancer patients should find ways to be physically active during and after treatment: New national guidelines

Postdoctoral scientists receive NYSCF-Druckenmiller Fellowship award

Men with ED are at increased risk of high CACS: Researchers

CoaguSense unveils first portable point-of-care PT/INR Monitoring System for patients on oral anticoagulants

Targeted Genetics reports net income of $1.8M for fourth-quarter 2009 compared to net loss of $10.8M in 2008

Odds of surviving cardiac arrest may depend on neighborhood: Study

Race matching among donors and recipients has no effect on survival rates: Study

Canadian Diabetes Association supports TELUS Health Solutions' new online consumer ehealth service

Alcohol consumption in Portugal represents heavy economic burden for that country's health system

Women unaware of their heart disease risk: Report

DNAzymes and substrates constitute a platform for logic operations essential to computational processes

Brain's cardiovascular, hormonal and asymmetric activation response when we get angry: UV scientists

FAIR-HF study: Ferinject improves renal function in patients with CHF and iron deficiency

Researchers identify pattern of gene expression in kidney transplant recipients who don't need anti-rejection drugs

Celladon announces 6-month data from Phase 2 clinical trial of MYDICAR in advanced heart failure patients

Adenosine plays major role in parlaying effects of acupuncture

Overall increase of cesarean births not due to maternal request

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Heart Disease News and Research

Latest Heart Disease News and Research

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Newsletters you may be interested in